129798-91-0

Basic information

• Product Name: 2-Piperazinecarboxylic acid, ethyl ester, dihydrochloride
• Synonyms: 2-Piperazinecarboxylic acid, ethyl ester, dihydrochloride
• CAS NO: 129798-91-0
• Molecular Formula: C7H16Cl2N2O2
• Molecular Weight: 231.12014
• Mol File: 129798-91-0.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 2-Piperazinecarboxylic acid, ethyl ester, dihydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Piperazinecarboxylic acid, ethyl ester, dihydrochloride(129798-91-0)
• EPA Substance Registry System: 2-Piperazinecarboxylic acid, ethyl ester, dihydrochloride(129798-91-0)

Safety Data

• Hazardous Substances Data: 129798-91-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Piperazinecarboxylic acid, ethyl ester, dihydrochloride is used as a key intermediate for the synthesis of various drugs and pharmaceutical products. Its versatile chemical structure allows for the creation of a wide range of medications, contributing to the development of novel therapeutic agents and enhancing the efficacy of existing ones.
Used in Organic Compound Synthesis:
In the field of organic chemistry, 2-Piperazinecarboxylic acid, ethyl ester, dihydrochloride is employed as a valuable building block for the synthesis of diverse organic compounds. Its reactivity and functional groups enable the formation of complex molecules with potential applications in various industries, including pharmaceuticals, agrochemicals, and materials science.
Used in Drug Development:
2-Piperazinecarboxylic acid, ethyl ester, dihydrochloride is utilized as a starting material in drug development, facilitating the design and synthesis of new pharmaceutical agents. Its presence in the synthesis process allows researchers to explore innovative drug candidates with improved pharmacological properties, such as increased potency, selectivity, and reduced side effects.
Used in Medication Production:
As a fundamental component in the production of various medications, 2-Piperazinecarboxylic acid, ethyl ester, dihydrochloride plays a critical role in the healthcare sector. Its incorporation into the manufacturing process of different drugs ensures the availability of essential medicines for the treatment and management of numerous medical conditions.

Upstream product

• 72351-59-8 ethyl 1,4-dibenzylpiperazin-2-carboxylate 

Relevant articles and documents

2-carboxyl piperazine linked tacrine-8-amino(hydroxyl) quinoline derivative as well as preparation and application

The invention relates to the technical field of chemical synthesis, and specifically relates to a 2-carboxyl piperazine linked tacrine-8-amino(hydroxyl) quinoline derivative as well as preparation andapplication. The 2-carboxyl piperazine linked tacrine-8-amino(hydroxyl) quinoline derivative is a chemical compound shown in a formula I (the formula I is shown in the description) or a pharmaceutically acceptable salt thereof, and a solvent chemical compound, an enantiomer, a diastereoisomer, a tautomer or a mixture in any proportion of the chemical compound shown in the formula I or the pharmaceutically acceptable salt thereof, and includes a racemic mixture. Confirmed by a pharmacological test, the kind of chemical compound has an inhibiting effect on the activity of acetylcholinesterase(AChE) and butyrylcholinesterase(BuChE), and belongs to a cholinesterase inhibitor; the chemical compound also has an inhibiting effect on self-aggregation of beta-amyloid protein, and has delayed action on hydrolysis of acetylcholine and self-aggregation of the beta-amyloid protein, thereby improving the effect of the acetylcholine on a synapse, and finally realizing the purpose of effectively treating alzheimer's disease (AD).

COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USES AS IDH1 MUTANTS INHIBITORS FOR TREATING CANCERS

Provided are compounds of formula (I), wherein X, Y, Z, W, V, R2, R3 and m are defined as in the description. Their pharmaceutical compositions and their uses as IDH1 mutants inhibitors for treating cancers are also provided

HETEROCYCLIC AMIDE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS

Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted N-type or T-type calcium channel activity are disclosed. Specifically, a series of heterocyclic amides are disclosed of the general formula (I) where Z is N or CHNR2 and X is NR2, O, S, S=O or SO2. Among other definitions for R, R1, W and Y, the compounds of formula (1) are further characterized by at least one of W or Y being CR3Ar2 where Ar is an aromatic or heteroaromatic ring (for example, where W or Y is a benzhydryl moiety).

Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity

The HIV-1 central nervous system infection leads to the onset of neurological impairments called AIDS dementia complex (ADC). PAF plays an important role in this pathology, as it is an HIV-1-induced neurotoxin produced by infected or activated macrophages

Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 1. Synthesis and biological activities of N-benzyl-N'-(arylalkyl)-2-(4',5'-dihydro-1'H-imidazol-2'- yl)piperazines

The physiopathology of non-insulin-dependent diabetes mellitus is associated with a dysfunction in the regulation of insulin secretion. The α2-adrenoceptors have been reported to be involved in this alteration, although α2-antagonist